Market Overview
| Study Period | 2019 - 2030 |
|---|---|
| Base Year For Estimation | 2024 |
| Forecast Data Period | 2025 - 2030 |
| Market Size (2025) | USD 0.93 Billion |
| Market Size (2030) | USD 1.31 Billion |
| Growth Rate (2025 - 2030) | 7.00% CAGR |
| Market Concentration | Medium |
Major Players
*Disclaimer: Major Players sorted in no particular order Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0. |
|
Japan Blood Glucose Monitoring Devices Market Analysis by Mordor Intelligence
The Japan Blood Glucose Monitoring Devices Market size is estimated at USD 0.93 billion in 2025, and is expected to reach USD 1.31 billion by 2030, at a CAGR of 7% during the forecast period (2025-2030).
The Japan Blood Glucose Monitoring Devices Market size is estimated at USD 0.93 billion in 2025, and is expected to reach USD 1.31 billion by 2030, at a CAGR of 7% during the forecast period (2025-2030).
As of April 2023, the JMDC database housed information from around 16 million patients, encompassing both healthy individuals and a specific subset dedicated to patients with diabetes mellitus. Individuals who have both type 2 diabetes (T2D) and metabolic syndrome are at a higher risk of developing cardiovascular disease in comparison to those with T2D but without metabolic syndrome.
While Type 1 diabetes is caused by an immune system malfunction, Type 2 diabetes is linked to leading a sedentary lifestyle, which results in the development of inherent resistance to insulin. Hence, Type 1 diabetes can be characterized as insulin-requiring, while Type 2 diabetes can be characterized as insulin-dependent diabetes. Japan has one of the largest elderly populations in the world, which is more susceptible to the onset of type 2 diabetes. As Japan's population continues to age, the prevalence of diabetes increases as well. The monitoring and management of blood glucose levels are on the rise, to avoid negative consequences, such as cardiovascular diseases, kidney disorders, and many other conditions.
The rising number of diabetes cases in Japan is fueling the growth of the market for blood glucose devices in several ways. Firstly, as the prevalence of diabetes increases, there is a greater demand for blood glucose monitoring devices among individuals with the condition. This has led to an increased adoption of these devices, driving the market growth.
Secondly, the Japanese government has been actively promoting diabetes management and prevention programs, which has further contributed to the growth of the market. These programs often emphasize the importance of regular blood glucose monitoring, leading to an increased awareness and demand for blood glucose devices.
Additionally, advancements in technology have led to the development of more accurate and user-friendly blood glucose devices. These devices often come with features such as wireless connectivity, smartphone integration, and continuous glucose monitoring, making them more convenient and appealing to individuals with diabetes. The availability of such advanced devices has also contributed to the market growth.
Therefore, owing to the aforementioned factors the studied market is anticipated to witness growth over the analysis period.
Japan Blood Glucose Monitoring Devices Market Trends and Insights
Increasing Type-1 diabetes population across Japan
While Type 1 diabetes is caused by an immune system malfunction, Type 2 diabetes is linked to leading a sedentary lifestyle, resulting in inherent resistance to insulin. Hence, Type 1 diabetes can be characterized as insulin-requiring, while Type 2 diabetes can be characterized as insulin-dependent diabetes.
Japan has one of the largest elderly populations in the world, which is more susceptible to the onset of Type 2 diabetes. As Japan's population continues to age, the prevalence of diabetes also increases. Monitoring and managing blood glucose levels are on the rise to avoid negative consequences, such as cardiovascular diseases, kidney disorders, and many other conditions.
The rise in diabetes cases in Japan is thought to be due to an increase in the number of older adults, who are more vulnerable to disease, and an increase in obesity due to a lack of exercise and irregular eating habits. Another reason is that more people have been diagnosed with the disease after being directed to a medical facility based on the results of the metabolic syndrome examination, which was introduced in 2008 to prevent lifestyle-related diseases. Diabetes cases are expected to increase even further in the coming years as Japan's society ages.
As a result of the factors above, the growth of the studied market in Russia is anticipated.
Continuous Glucose Monitoring Holds Highest CAGR in Japan Blood Glucose Monitoring Devices Market.
Diabetes is a complex and chronic disease that can cause blindness, neuropathy, kidney disease, myocardial infarction, or stroke. Patients must control their glucose levels daily to avoid aggravation and the onset of complications. Apps for real-time continuous glucose monitoring (CGM) on smartphones and other devices linked to CGM systems have recently been developed, and such CGM apps are also being used in Japan. Compared to traditional retrospective CGM, using CGM apps improves patients' blood glucose control, which is expected to help slow the progression of Type 2 diabetes mellitus (DM) and prevent complications.
Continuous glucose monitoring sensors use glucose oxidase to detect blood sugar levels. Glucose oxidase converts glucose to hydrogen peroxidase, which reacts with the platinum inside the sensor, producing an electrical signal to be communicated to the transmitter. Sensors are the most important part of continuous glucose monitoring devices. Technological advancements to improve the accuracy of the sensors are expected to drive segment growth during the forecast period.
Monthly dialysis medical costs average around 400,000 per person and around 1.6 trillion annually for the country, accounting for roughly 4% of all medical expenditures. It is, therefore, critical to improve the daily habits of those at risk of diabetes and to keep those who have already contracted the disease from worsening.
The increased diabetic prevalence in Russia and the above factors will likely drive segment growth during the forecast period.
Competitive Landscape
The blood glucose monitoring devices market is highly fragmented, with a few major manufacturers present in the market. Major players, such as Dexcom, Medtronic, Abbott, and Senseonics, dominate the CGM device market. The demand for BGM devices is driven by more generic players, such as Roche, LifeScan, Arkray, and Ascensia. Recent technological innovations have helped companies strengthen their market presence.
Japan Blood Glucose Monitoring Devices Industry Leaders
-
Roche
-
Abbott
-
Medtronics
-
Dexcom
-
LifeScan
- *Disclaimer: Major Players sorted in no particular order
Need More Details on Market Players and Competitors?
Download PDF
Recent Industry Developments
- June 2023: Kakao Healthcare is set to introduce a diabetes management service powered by Dexcom. As stated in a press release, this collaboration leverages Kakao Healthcare's expertise in AI and software technology, along with Dexcom's advanced continuous glucose monitoring (CGM) devices, namely Dexcom G6 and G7. It is worth noting that Dexcom is currently in the process of obtaining approval from the Ministry of Food and Drug Safety for these devices.
- May 2022: Terumo announces that the indication for the Dexcom G6 CGM System has changed in Japan. With this new indication, the Dexcom G6 CGM System will be the only real-time continuous glucose monitoring system (RT-CGM) in Japan that can be used principally for the day-to-day management of blood glucose levels without the adjunctive use of a blood glucose meter.
Japan Blood Glucose Monitoring Devices Market Report Scope
Japan Blood Glucose Monitoring Devices Market witnessed USD 0.7 billion in the current year and is anticipated to register a CAGR of over 5% during the forecast period. Japan Blood Glucose Monitoring Devices Market is segmented into Type, Component. The report offers the value (in USD) and volume (in Units) for the above segments.
Self-monitoring blood glucose devices
| Glucometer Devices |
| Test Strips |
| Lancets |
Continuous blood glucose monitoring devices
| Sensors |
| Durables (Receivers and Transmitters) |
| Self-monitoring blood glucose devices | Glucometer Devices |
| Test Strips | |
| Lancets | |
| Continuous blood glucose monitoring devices | Sensors |
| Durables (Receivers and Transmitters) |
Need A Different Region or Segment?
Customize Now
Key Questions Answered in the Report
How big is the Japan Blood Glucose Monitoring Devices Market?
The Japan Blood Glucose Monitoring Devices Market size is expected to reach USD 0.93 billion in 2025 and grow at a CAGR of 7% to reach USD 1.31 billion by 2030.
What is the current Japan Blood Glucose Monitoring Devices Market size?
In 2025, the Japan Blood Glucose Monitoring Devices Market size is expected to reach USD 0.93 billion.
Who are the key players in Japan Blood Glucose Monitoring Devices Market?
Roche, Abbott, Medtronics, Dexcom and LifeScan are the major companies operating in the Japan Blood Glucose Monitoring Devices Market.
What years does this Japan Blood Glucose Monitoring Devices Market cover, and what was the market size in 2024?
In 2024, the Japan Blood Glucose Monitoring Devices Market size was estimated at USD 0.86 billion. The report covers the Japan Blood Glucose Monitoring Devices Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Japan Blood Glucose Monitoring Devices Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.
Page last updated on:
